vs
Side-by-side financial comparison of Royalty Pharma plc (RPRX) and WillScot Holdings Corp (WSC). Click either name above to swap in a different company.
Royalty Pharma plc is the larger business by last-quarter revenue ($622.0M vs $566.0M, roughly 1.1× WillScot Holdings Corp). Royalty Pharma plc runs the higher net margin — 34.4% vs -33.1%, a 67.5% gap on every dollar of revenue. On growth, Royalty Pharma plc posted the faster year-over-year revenue change (4.8% vs -6.1%). Over the past eight quarters, Royalty Pharma plc's revenue compounded faster (4.6% CAGR vs -1.8%).
Acceleron Pharma, Inc. is an American clinical stage biopharmaceutical company based in Cambridge, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta (TGF-β) superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red blood cells, muscle, bone, and blood vessels.
WillScot Holdings Corp is a leading provider of modular space solutions and portable storage services across North America. It serves a wide range of sectors including construction, commercial development, education, healthcare, government projects, and special events, offering flexible, scalable temporary and semi-permanent space solutions tailored to diverse client needs.
RPRX vs WSC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $622.0M | $566.0M |
| Net Profit | $214.2M | $-187.3M |
| Gross Margin | — | 50.4% |
| Operating Margin | 62.4% | -32.5% |
| Net Margin | 34.4% | -33.1% |
| Revenue YoY | 4.8% | -6.1% |
| Net Profit YoY | 2.9% | -310.0% |
| EPS (diluted) | $0.49 | $-1.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $622.0M | $566.0M | ||
| Q3 25 | $609.3M | $566.8M | ||
| Q2 25 | $578.7M | $589.1M | ||
| Q1 25 | $568.2M | $559.6M | ||
| Q4 24 | $593.6M | $602.5M | ||
| Q3 24 | $564.7M | $601.4M | ||
| Q2 24 | $537.3M | $604.6M | ||
| Q1 24 | $568.0M | $587.2M |
| Q4 25 | $214.2M | $-187.3M | ||
| Q3 25 | $288.2M | $43.3M | ||
| Q2 25 | $30.2M | $47.9M | ||
| Q1 25 | $238.3M | $43.1M | ||
| Q4 24 | $208.2M | $89.2M | ||
| Q3 24 | $544.0M | $-70.5M | ||
| Q2 24 | $102.0M | $-46.9M | ||
| Q1 24 | $4.8M | $56.2M |
| Q4 25 | — | 50.4% | ||
| Q3 25 | — | 49.7% | ||
| Q2 25 | — | 50.3% | ||
| Q1 25 | — | 53.7% | ||
| Q4 24 | — | 55.8% | ||
| Q3 24 | — | 53.5% | ||
| Q2 24 | — | 54.1% | ||
| Q1 24 | — | 54.0% |
| Q4 25 | 62.4% | -32.5% | ||
| Q3 25 | 70.1% | 21.0% | ||
| Q2 25 | 36.3% | 21.5% | ||
| Q1 25 | 94.0% | 21.3% | ||
| Q4 24 | 60.9% | 28.9% | ||
| Q3 24 | — | -5.9% | ||
| Q2 24 | 50.2% | -0.9% | ||
| Q1 24 | -13.0% | 22.1% |
| Q4 25 | 34.4% | -33.1% | ||
| Q3 25 | 47.3% | 7.6% | ||
| Q2 25 | 5.2% | 8.1% | ||
| Q1 25 | 41.9% | 7.7% | ||
| Q4 24 | 35.1% | 14.8% | ||
| Q3 24 | 96.3% | -11.7% | ||
| Q2 24 | 19.0% | -7.7% | ||
| Q1 24 | 0.8% | 9.6% |
| Q4 25 | $0.49 | $-1.02 | ||
| Q3 25 | $0.67 | $0.24 | ||
| Q2 25 | $0.07 | $0.26 | ||
| Q1 25 | $0.55 | $0.23 | ||
| Q4 24 | $0.46 | $0.48 | ||
| Q3 24 | $1.21 | $-0.37 | ||
| Q2 24 | $0.23 | $-0.25 | ||
| Q1 24 | $0.01 | $0.29 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $618.7M | $14.6M |
| Total DebtLower is stronger | $9.0B | $3.6B |
| Stockholders' EquityBook value | $9.7B | $856.3M |
| Total Assets | $19.6B | $5.8B |
| Debt / EquityLower = less leverage | 0.92× | 4.15× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $618.7M | $14.6M | ||
| Q3 25 | $938.9M | $14.8M | ||
| Q2 25 | $631.9M | $12.8M | ||
| Q1 25 | $1.1B | $10.7M | ||
| Q4 24 | $929.0M | $9.0M | ||
| Q3 24 | $950.1M | $11.0M | ||
| Q2 24 | $1.8B | $5.9M | ||
| Q1 24 | $843.0M | $13.1M |
| Q4 25 | $9.0B | $3.6B | ||
| Q3 25 | $8.9B | $3.6B | ||
| Q2 25 | $8.0B | $3.7B | ||
| Q1 25 | $7.6B | $3.6B | ||
| Q4 24 | $7.6B | $3.7B | ||
| Q3 24 | $7.6B | $3.6B | ||
| Q2 24 | $7.6B | $3.5B | ||
| Q1 24 | $6.1B | $3.5B |
| Q4 25 | $9.7B | $856.3M | ||
| Q3 25 | $9.6B | $1.1B | ||
| Q2 25 | $9.5B | $1.0B | ||
| Q1 25 | $9.8B | $1.0B | ||
| Q4 24 | $10.3B | $1.0B | ||
| Q3 24 | $10.3B | $1.1B | ||
| Q2 24 | $9.8B | $1.2B | ||
| Q1 24 | $9.9B | $1.3B |
| Q4 25 | $19.6B | $5.8B | ||
| Q3 25 | $19.3B | $6.1B | ||
| Q2 25 | $18.3B | $6.1B | ||
| Q1 25 | $17.6B | $6.0B | ||
| Q4 24 | $18.2B | $6.0B | ||
| Q3 24 | $18.0B | $6.0B | ||
| Q2 24 | $17.7B | $6.0B | ||
| Q1 24 | $16.1B | $6.2B |
| Q4 25 | 0.92× | 4.15× | ||
| Q3 25 | 0.93× | 3.39× | ||
| Q2 25 | 0.84× | 3.55× | ||
| Q1 25 | 0.78× | 3.56× | ||
| Q4 24 | 0.74× | 3.62× | ||
| Q3 24 | 0.74× | 3.42× | ||
| Q2 24 | 0.78× | 2.88× | ||
| Q1 24 | 0.62× | 2.63× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $827.1M | $158.9M |
| Free Cash FlowOCF − Capex | — | $149.7M |
| FCF MarginFCF / Revenue | — | 26.5% |
| Capex IntensityCapex / Revenue | — | 1.6% |
| Cash ConversionOCF / Net Profit | 3.86× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $737.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $827.1M | $158.9M | ||
| Q3 25 | $702.6M | $191.2M | ||
| Q2 25 | $364.0M | $205.3M | ||
| Q1 25 | $596.1M | $206.6M | ||
| Q4 24 | $742.5M | $178.9M | ||
| Q3 24 | $703.6M | $-1.6M | ||
| Q2 24 | $658.2M | $175.6M | ||
| Q1 24 | $664.6M | $208.7M |
| Q4 25 | — | $149.7M | ||
| Q3 25 | — | $186.9M | ||
| Q2 25 | — | $199.0M | ||
| Q1 25 | — | $202.0M | ||
| Q4 24 | — | $176.6M | ||
| Q3 24 | — | $-4.9M | ||
| Q2 24 | — | $169.4M | ||
| Q1 24 | — | $202.1M |
| Q4 25 | — | 26.5% | ||
| Q3 25 | — | 33.0% | ||
| Q2 25 | — | 33.8% | ||
| Q1 25 | — | 36.1% | ||
| Q4 24 | — | 29.3% | ||
| Q3 24 | — | -0.8% | ||
| Q2 24 | — | 28.0% | ||
| Q1 24 | — | 34.4% |
| Q4 25 | — | 1.6% | ||
| Q3 25 | — | 0.7% | ||
| Q2 25 | — | 1.1% | ||
| Q1 25 | — | 0.8% | ||
| Q4 24 | — | 0.4% | ||
| Q3 24 | — | 0.6% | ||
| Q2 24 | — | 1.0% | ||
| Q1 24 | — | 1.1% |
| Q4 25 | 3.86× | — | ||
| Q3 25 | 2.44× | 4.41× | ||
| Q2 25 | 12.06× | 4.28× | ||
| Q1 25 | 2.50× | 4.80× | ||
| Q4 24 | 3.57× | 2.01× | ||
| Q3 24 | 1.29× | — | ||
| Q2 24 | 6.45× | — | ||
| Q1 24 | 139.10× | 3.71× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
WSC
| Modular Space Leasing | $249.8M | 44% |
| Value Added Product And Services | $101.0M | 18% |
| Portable Storage Leasing | $83.0M | 15% |
| Delivery Revenue | $48.2M | 9% |
| Installation Revenue | $45.0M | 8% |
| Rental Units | $19.7M | 3% |
| New Units | $15.5M | 3% |
| Value Added Services | $10.3M | 2% |
| Other Leasing Related Products And Services | $3.8M | 1% |
